GEMINI study

October 18, 2017

Entyvio Eased Early Symptoms of Ulcerative Colitis and Crohn’s, New Analysis Shows

News

Entyvio (vedolizumab) alleviated some of the early symptoms of patients with moderate to severe ulcerative colitis and Crohn’s disease, a new analysis of Phase 3 trial results indicates. Takeda Pharmaceutical presented the ... Read more

February 22, 2017

Entyvio for IBD Shows Promising Safety Results in Long-term Clinical Trial

News

Takeda Pharmaceuticals recently presented positive five-year results of an eight-year clinical trial (NCT00790933) evaluating the long-term safety of Entyvio (vedolizumab) in patients with active ulcerative colitis and Crohn’s disease, two of the ... Read more